← News·MarketsMarkets

AstraZeneca investors push back on $400bn Bristol Myers Squibb tie-up

A potential $400 billion combination between AstraZeneca (AZN) and Bristol Myers Squibb (BMY) is meeting organized resistance from AstraZeneca's own shareholders before any definitive agreement has been filed. Investors…

NM
NewsMV Markets Desk
3 min read
3 August 2026Markets desk
Share this dispatch
TickersMSAMZN
Categoryregulatory

Filed via ft.com

Keep reading

More from the markets desk